What is the CPT code for a TSH‑receptor antibody (TRAb) assay?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CPT Code for TSH Receptor Antibodies

The CPT code for TSH receptor antibody (TRAb) testing is 83520 (Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specified).

Understanding the Test and Coding

While the provided evidence focuses extensively on the clinical utility and diagnostic performance of TRAb assays in Graves' disease 1, the specific CPT coding is standardized through the American Medical Association's Current Procedural Terminology system.

Key Points About TRAb Testing:

  • Modern assays use either competitive binding immunoassays (measuring all TSH-R antibodies regardless of function) or bioassays that specifically measure thyroid stimulating immunoglobulin (TSI) function 2, 3

  • Third-generation assays using monoclonal antibody M22 or similar techniques show clinical sensitivity and specificity approaching 100% for Graves' disease diagnosis 1, 4, 5

  • Both TRAb and TSI assays are strongly correlated (r=0.873) and show good clinical agreement, making paired ordering of both tests redundant and potentially wasteful 3, 6

Clinical Context:

The guidelines emphasize that anti-TSH-R antibody assay is recommended as first-line testing when Graves' disease is suspected, particularly in typical presentations (young female, ophthalmopathy, homogeneous goiter), where positive results provide near 100% positive predictive value 1.

Common pitfall: Some laboratories may use different CPT codes depending on the specific methodology (competitive binding vs. bioassay), so verify with your specific laboratory's billing department for their preferred coding, as some may use 86376 (Microsomal antibodies) or other codes depending on their interpretation of the test methodology.

References

Guideline

diagnostic procedure in suspected graves' disease.

Annales d'endocrinologie, 2018

Research

TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2020

Related Questions

Can you have both positive Thyroid-Stimulating Hormone (TSH) receptor antibody and Thyroid Peroxidase (TPO) antibody?
How often should thyrotropin‑receptor antibodies (TRAb) and thyroid peroxidase antibodies (TPOAb) be checked after initiating methimazole therapy?
For a 77-year-old woman with a mildly suppressed thyroid‑stimulating hormone, normal free thyroxine and total triiodothyronine, and negative thyroid‑stimulating immunoglobulin and thyrotropin‑binding inhibitor immunoglobulin, is watchful waiting appropriate?
Are Graves disease (TSH‑receptor) antibodies useful when TSH is elevated, or are they only indicated for hyperthyroidism?
When do current guidelines recommend ordering thyroid antibody testing (anti‑thyroperoxidase, anti‑thyroglobulin, and TSH‑receptor antibodies) and in which clinical scenarios should it be performed?
Can a patient with G6PD deficiency safely take oral vitamin B12 (cobalamin), vitamin B6 (pyridoxine), and vitamin B9 (folic acid), and what are the recommended dosing regimens?
What is the appropriate indapamide dosage for treating edema in an adult, and how should the dose be adjusted for elderly patients or those with impaired renal function?
How should stress-dose glucocorticoid therapy be initiated and tapered in a critically ill patient with suspected adrenal insufficiency?
How can I identify volume depletion in a patient?
What is the recommended steroid taper regimen for a patient with giant cell arteritis who has vision loss?
What is the recommended pain control regimen for a male patient with a chronic indwelling Foley catheter?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.